Effect of nebolized G-CSF in treatment of Ventilator Associated Pneumonia (VAP)

Phase 3

• Conditions: Ventilator associated pneumonia.; other infectious diseases; B99-B99

• Registration Number: IRCT20150824023743N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age over 18 years
Mechanical ventilation more than 48 hours
Multidrug resistance Acinetobacter in tracheal culture
Satisfaction with the first class family

Exclusion Criteria

Allergy to Colistin
Other infections

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Achieve in treatment. Timepoint: 1,3,5,7 and 14 days after intervention. Method of measurement: Calculate the Clinical Pulmonary Infection Score table.